ADBE
56
-13
PGR
69
4
CNP
54
4
BMY
63
7
NI
67
2
SBUX
45
-2
NSC
60
-7
FLR
48
6
ILMN
38
2
EQR
59
2
AMGN
63
3
VRSK
56
16
STI
45
10
LEG
25
5
PRGO
50
3
PBI
60
14
MCK
52
6
GT
43
2
PX
52
2
CF
59
3
ADBE
56
-13
PGR
69
4
CNP
54
4
BMY
63
7
NI
67
2
SBUX
45
-2
NSC
60
-7
FLR
48
6
ILMN
38
2
EQR
59
2
AMGN
63
3
VRSK
56
16
STI
45
10
LEG
25
5
PRGO
50
3
PBI
60
14
MCK
52
6
GT
43
2
PX
52
2
CF
59
3
Financhill
Back

ACADIA Pharmaceuticals Vs. Supernus Pharmaceuticals Industry Stock Comparison

Buy
52

ACAD
ACADIA Pharmaceuticals

Last Price:
16.36
Seasonality Move:
2.03%
Sell
21

SUPN
Supernus Pharmaceuticals

Last Price:
31.50
Seasonality Move:
-9.35%
Buy
52
ACADIA Pharmaceuticals (ACAD) is a Buy

Is ACADIA Pharmaceuticals a Buy, Sell or Hold?

  • The current ACADIA Pharmaceuticals [ACAD] share price is $16.32. The Score for ACAD is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • ACAD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
21
Supernus Pharmaceuticals (SUPN) is a Sell

Is Supernus Pharmaceuticals a Buy, Sell or Hold?

  • The current Supernus Pharmaceuticals [SUPN] share price is $31.11. The Score for SUPN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • SUPN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACAD Stock Price Chart

What is ACADIA Pharmaceuticals's stock price today?

  • The ACADIA Pharmaceuticals share price today is $16.32
    The current trend is relatively stagnant and ACAD is experiencing buying pressure, which is a positive indicator for future bullish movement.

SUPN Stock Price Chart

What is Supernus Pharmaceuticals's stock price today?

  • The Supernus Pharmaceuticals share price today is $31.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.

ACAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 51.15 Buy
Chaikin Money Flow: 640185 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.49 - 16.25) Buy
Bollinger Bands (100): (15.04 - 17.5) Buy

SUPN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 36.67 Sell
Chaikin Money Flow: -354809 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.55 - 35.13) Sell
Bollinger Bands (100): (26.96 - 32.62) Buy

ACAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.08 Buy
20-day SMA: 15.98 Buy
50-day SMA: 16.89 Sell
200-day SMA: 20.1 Sell
8-day EMA: 16.06 Buy
20-day EMA: 16.14 Buy
50-day EMA: 16.43 Sell
200-day EMA: 18.79 Sell

SUPN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.96 Sell
20-day SMA: 34.01 Sell
50-day SMA: 31.51 Sell
200-day SMA: 29.68 Buy
8-day EMA: 32.51 Sell
20-day EMA: 33.08 Sell
50-day EMA: 31.92 Sell
200-day EMA: 30.29 Buy

ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.56 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.88 per share, and an increase next year of $0.31 per share.

Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.

ACADIA Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Supernus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):